Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.70 Insider Own0.10% Shs Outstand162.59M Perf Week10.53%
Market Cap1.42B Forward P/E- EPS next Y-0.77 Insider Trans-93.88% Shs Float162.59M Perf Month61.90%
Income-100.50M PEG- EPS next Q-0.18 Inst Own92.40% Short Float9.82% Perf Quarter141.94%
Sales161.00M P/S8.80 EPS this Y-18.50% Inst Trans18.98% Short Ratio2.35 Perf Half Y139.94%
Book/sh-0.36 P/B- EPS next Y0.00% ROA-54.90% Target Price10.13 Perf Year121.63%
Cash/sh0.72 P/C12.15 EPS next 5Y10.00% ROE406.00% 52W Range2.38 - 8.30 Perf YTD106.40%
Dividend- P/FCF- EPS past 5Y8.60% ROI-108.50% 52W High4.94% Beta2.21
Dividend %- Quick Ratio2.50 Sales past 5Y13.90% Gross Margin84.00% 52W Low265.97% ATR0.42
Employees177 Current Ratio2.50 Sales Q/Q142.60% Oper. Margin-55.50% RSI (14)72.23 Volatility5.85% 5.81%
OptionableYes Debt/Eq- EPS Q/Q-33.60% Profit Margin-62.40% Rel Volume0.62 Prev Close8.21
ShortableYes LT Debt/Eq- EarningsNov 01 BMO Payout- Avg Volume6.79M Price8.71
Recom1.60 SMA2019.17% SMA5030.17% SMA200109.16% Volume4,190,947 Change6.09%
Sep-26-16Reiterated Piper Jaffray Overweight $7 → $10
Sep-26-16Reiterated Leerink Partners Outperform $6 → $9
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Dec-03-16 03:33PM  Why Array BioPharma Rose 32.5% in November at Motley Fool
Nov-22-16 10:00AM  Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-15-16 12:27PM  Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks? at Insider Monkey
Nov-10-16 11:07AM  Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And Its Impressive at Insider Monkey
03:06AM  Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data at Insider Monkey
Nov-09-16 01:04PM  ARRAY BIOPHARMA INC Financials +7.43%
10:19AM  The Market Offers Some Opportunities but They're Disappearing Fast
10:17AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:00AM  COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress PR Newswire
Nov-08-16 02:00PM  Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences PR Newswire
Nov-06-16 10:15AM  7 Analyst Stocks Under $10 for Massive Upside Projections at 24/7 Wall St.
Nov-04-16 08:50AM  Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More at 24/7 Wall St. +8.92%
Nov-03-16 08:38AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report -7.88%
Nov-01-16 04:01PM  Edited Transcript of ARRY earnings conference call or presentation 1-Nov-16 1:00pm GMT +7.19%
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:30AM  Array BioPharma reports 1Q loss
08:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017 PR Newswire
07:07AM  Q1 2017 Array Biopharma Inc Earnings Release - Before Market Open
Oct-31-16 02:09PM  Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed
11:08AM  Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology PR Newswire
Oct-25-16 04:31PM  Array BioPharma And Pierre Fabre To Present Phase 3 COLUMBUS Trial At Society For Melanoma Research Annual Congress PR Newswire
11:00AM  Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016 PR Newswire
Oct-14-16 10:10AM  Array BioPharma (ARRY) is in Overbought Territory: What's Next?
Oct-11-16 10:05AM  ETFs with exposure to Array BioPharma, Inc. : October 11, 2016
Oct-10-16 11:21AM  Why Array BioPharma Skyrocketed 91% in September at Motley Fool
Oct-09-16 11:13AM  3 Cancer Drugs That Could Get an FDA OK Next Year at Motley Fool
Oct-03-16 10:12AM  Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares PR Newswire
08:39AM  6 Best Performing Drug Stocks of September
Oct-02-16 10:05AM  Top 6 Biopharma Gainers of the Past Week at 24/7 Wall St.
Sep-29-16 11:12PM  Array Announces $100M Public Offering (ARRY) at Investopedia
Sep-28-16 05:55PM  Array BioPharma Reports Positive Results (ARRY) at Investopedia
04:50PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
09:59AM  Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending at Insider Monkey
Sep-27-16 09:23PM  Array BioPharma Announces Pricing of Public Offering of Common Stock PR Newswire
06:20PM  3 Reasons to Buy Array Biopharma at Motley Fool
04:27PM  Array BioPharma Announces Proposed Public Offering of Common Stock PR Newswire
02:01PM  ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today at Insider Monkey
12:50PM  Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success
11:49AM  Momentum Carries Lululemon Lower, Pushes Biotech Names Higher at Forbes
09:51AM  ETFs with exposure to Array BioPharma, Inc. : September 27, 2016
09:42AM  Array (ARRY) Hits 52-Week High on Positive Phase III Data
08:45AM  Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More at 24/7 Wall St.
Sep-26-16 10:58PM  Futures Swing Into Positive Territory During Debate, Asia Lower +81.10%
06:03PM  Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today at Motley Fool
01:35PM  5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy
12:49PM  Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today at Insider Monkey
12:11PM  Why Array BioPharma Inc Is Surging Today at Motley Fool
12:10PM  Array Biopharma Shares Soar on Melanoma Trials Early Results
11:50AM  Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target
10:15AM  4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate at 24/7 Wall St.
09:20AM  Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma at The Wall Street Journal
09:00AM  Array Biopharma Inc Conference Call regarding Phase 3 COLUMBUS study scheduled for 9:00 am ET today
07:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint PR Newswire
Sep-24-16 12:09PM  3 Biotechs That Could Be M&A Targets at Motley Fool
Sep-21-16 01:38PM  5 Stocks Insiders Love Right Now
11:23AM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : September 21, 2016
Sep-20-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016
Sep-18-16 10:15AM  10 Analyst Stock Picks Under $10 for Massive Upside at 24/7 Wall St.
Sep-14-16 08:25PM  Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY) at Investopedia
12:08PM  Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today at Insider Monkey
08:20AM  Key FDA Decisions and Trial Results Coming in the Next 2 Months at 24/7 Wall St.
07:33AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA PR Newswire
Sep-12-16 01:55PM  Why Array Biopharma May Become a Winner (ARRY) at Investopedia +5.56%
Sep-11-16 04:00PM  How To Approach Momentum Trading Like A Pro at Investopedia
Sep-09-16 08:12AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 9, 2016 -6.81%
Sep-06-16 11:00AM  Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference PR Newswire
Sep-04-16 10:40AM  5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside at 24/7 Wall St.
Sep-02-16 04:19PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
02:33PM  What Are Array Biopharma Inc (ARRY)s Chances Of PDUFA Success? at Insider Monkey
09:29AM  Array (ARRY) Oncology Drug Accepted for Review in the U.S.
07:40AM  8 Major FDA Decisions and Trial Results to Watch for in September at 24/7 Wall St.
Sep-01-16 08:04AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma PR Newswire
Aug-31-16 11:28AM  Array (ARRY) Presents Positive Cardiovascular Trial Data
09:00AM  Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference PR Newswire
Aug-30-16 12:20PM  Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win at 24/7 Wall St.
08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress PR Newswire
Aug-29-16 03:51PM  Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies +6.17%
08:55AM  Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More at 24/7 Wall St.
Aug-23-16 11:20AM  ETFs with exposure to Array BioPharma, Inc. : August 23, 2016
Aug-22-16 09:40AM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016 +6.48%
Aug-19-16 03:26PM  Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress PR Newswire -6.90%
08:32AM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report
Aug-14-16 10:05AM  Top 6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-11-16 12:31PM  ETFs with exposure to Array BioPharma, Inc. : August 11, 2016
Aug-10-16 12:54PM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016
10:55AM  Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08:14AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016
Aug-09-16 03:37PM  Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial -22.70%
11:05AM  3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential at 24/7 Wall St.
07:40AM  Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals at MarketWatch
06:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:01AM  AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer PR Newswire
Aug-05-16 03:00PM  Edited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT
08:25AM  Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher
Aug-04-16 09:11AM  Array BioPharma reports 4Q loss +9.27%
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II clinical trials comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASLAN001/Varlitinib, a pan-HER2 inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; Prexasertib/LY2606368, a chk-1 inhibitor for cancer; LOXO-101, a PanTrk inhibitor for cancer; and ONT-380/ARRY-380, an HER2 inhibitor for breast cancer. The company's Phase I drugs include GDC-0994, an ERK inhibitor for cancer; and ARRY-382, a CSF1R inhibitor for cancer, as well as Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VAN LUNSEN GIL JDirectorOct 29Option Exercise5.835,00029,15010,260Oct 31 07:46 PM
BAUM CHARLES MDirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
Fyfe Gwen A.DirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
LEFKOFF KYLEDirectorOct 29Option Exercise5.835,00029,1508,585Oct 31 07:15 PM
Orwin John ADirectorOct 29Option Exercise5.835,00029,1505,000Oct 31 07:15 PM
Redmile Group, LLC10% OwnerSep 28Sale6.362,492,57815,852,79616,658,072Sep 30 03:55 PM
Sandor VictorChief Medical OfficerSep 22Option Exercise3.6995,890353,834200,733Sep 23 07:52 PM
Redmile Group, LLC10% OwnerSep 15Buy3.5028,00098,00019,150,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 15Sale3.547,30025,84219,122,650Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Buy3.51372,0001,305,72019,129,950Sep 16 04:00 PM
Redmile Group, LLC10% OwnerSep 14Sale3.50392,7001,374,45018,757,950Sep 16 04:00 PM
Redmile Group, LLC10% OwnerJan 12Buy3.6075,000270,00018,850,650Jan 14 04:14 PM
Redmile Group, LLC10% OwnerJan 11Buy3.54275,000973,50018,775,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 08Buy3.72350,0001,302,00018,500,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 07Buy3.73300,0001,119,00018,150,650Jan 11 07:33 PM